STAGE IV CERVICAL CANCER AJCC V8
Clinical trials for STAGE IV CERVICAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV CERVICAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV CERVICAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Drug-Radiation combo tested for Tough-to-Treat gynecologic cancers
Disease control Recruiting nowThis early-stage study is testing a new combination treatment for gynecologic cancers that have returned after previous therapy. Researchers are combining an oral drug called talazoparib with standard radiation therapy to see if it works better together. The main goal is to find …
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Custom-Made vaccine aims to train immune system to fight advanced cancers
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to target the unique proteins on a patient's own cancer cells. It is being given alongside an existing immunotherapy drug (pembrolizumab) to see if the combination is safe and can help control advanced solid tumors that h…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Mayo clinic tests 'Crystal Ball' for cancer treatment success
Knowledge-focused Recruiting nowThis study aims to collect tumor tissue samples from patients with various cancers to test a new diagnostic platform called Elephas. The goal is to see how accurately this tool can predict whether patients will respond to immunotherapy treatments before they begin. Researchers wi…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC
-
Major cancer center launches national registry for rare cervical cancer
Knowledge-focused Recruiting nowThis study is creating a registry to collect information from 750 patients with a rare and aggressive type of cervical cancer called neuroendocrine carcinoma. Researchers will review medical records and follow patients for up to 10 years to understand how different treatments aff…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:23 UTC